Jay A Markwalder

This inventor holds 23 USPTO granted patents and 2 published patent applications and 8 EPO patents, primarily in Immunotherapy Research. Top assignees: Bristol-Myers Squibb Compnay, Flexus Biosciences, Inc., Syngene International Limited. Active years: 2003-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jay A Markwalder. Retrieved from https://idiyas.com/inventor/jay-a-markwalder

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 2)

% Patents Active = 100.0

EPO Patents = 8 (Patent Applications = 11)

Average Co-Inventor Count = 7.1

ph-index = 6

Forward Citations = 85(Granted Patents)

Location History:

London University, PA (US) (2003)
New London, PA (US) (2010 - 2014)
Lahaska, PA (US) (2017 - 2024)
Princeton, NJ (US) (2024)

Company Filing History:

16 out of 3,745

Bristol-Myers Squibb Compnay

patents

5 out of 8

Flexus Biosciences, Inc.

patents

4 out of 7

Syngene International Limited

patents

4. 2 out of 106

Dupont Pharmaceuticals Company

patents

5. 2 out of 21

Innate Tumor Immunity, Inc.

patents

where one patent can have more than one assignee

Years Active: 2003-2025

Loading Chart...

Areas of Expertise:

NLRP3 Modulators

IDO Inhibitors

Immunoregulatory Agents

Cancer Treatment

Lysine Methyl Transferase

Protein Kinase Inhibitors

HMG-CoA Reductase

Cyclin Dependent Kinase

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12391675 - NLRP3 modulators (2025-08-19),

2. 12145927 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use (2024-11-19),

3. 12059420 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use (2024-08-13),

4. 12037344 - NLRP3 modulators (2024-07-16),

5. 10689331 - IDO inhibitors (2020-06-23),

6. 10533014 - Immunoregulatory agents (2020-01-14),

7. 10399933 - Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer (2019-09-03),

8. 10399932 - Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer (2019-09-03),

9. 10206893 - Immunoregulatory agents (2019-02-19),

10. 10167254 - IDO inhibitors (2019-01-01),

11. 10106546 - Immunoregulatory agents (2018-10-23),

12. 9895330 - IDO inhibitors (2018-02-20),

13. 9822103 - Inhibitors of lysine methyl transferase (2017-11-21),

14. 9790169 - IDO inhibitors (2017-10-17),

15. 9765018 - IDO inhibitors (2017-09-19),

Title: Jay A Markwalder - Pioneering Inventor from Lahaska, PA

Introduction: Jay A Markwalder is a distinguished inventor hailing from Lahaska, Pennsylvania. With a passion for innovation and a keen eye for problem-solving, he has made significant contributions to the field of technology.

Latest Patents: Jay A Markwalder holds several patents in various industries, including telecommunications, renewable energy, and consumer electronics. His recent patents focus on sustainable energy solutions and cutting-edge communication technologies.

Career Highlights: Throughout his career, Jay A Markwalder has been recognized for his groundbreaking inventions that have revolutionized the way we live and work. His commitment to pushing the boundaries of technology has led to numerous successful ventures and collaborations.

Collaborations: Jay A Markwalder has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work across disciplines and industries has resulted in innovative solutions that have had a lasting impact on society.

Conclusion: Jay A Markwalder's relentless pursuit of innovation and his dedication to creating a better future through technology make him a true pioneer in the world of inventions. His work continues to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.